Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
11.55 USD | -1.16% | +3.30% | +30.66% |
13/05 | Avalo Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
17/04 | North American Morning Briefing : Stock Futures -2- | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+30.66% | 12.08M | |
+49.36% | 54.63B | |
-4.89% | 39.92B | |
+37.55% | 38.82B | |
+15.30% | 26.86B | |
-12.56% | 26.22B | |
-21.87% | 18.78B | |
+25.85% | 12.21B | |
+1.98% | 12.16B | |
+26.66% | 11.94B |
- Stock Market
- Equities
- AVTX Stock
- News Avalo Therapeutics, Inc.
- Avalo Says Trial of AVTX-002 to Treat Non-Eosinophilic Asthma Did Not Meet Primary Endpoint; Shares Slump